This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Cell MedX Past Earnings Performance
Past criteria checks 0/6
Key information
11.3%
Earnings growth rate
23.3%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 28.5% |
| Return on equity | n/a |
| Net Margin | -37,440.5% |
| Last Earnings Update | 28 Feb 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Cell MedX makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 28 Feb 22 | 0 | -1 | 1 | 0 |
| 30 Nov 21 | 0 | -1 | 1 | 0 |
| 31 Aug 21 | 0 | -1 | 1 | 0 |
| 31 May 21 | 0 | -1 | 0 | 0 |
| 28 Feb 21 | 0 | -1 | 1 | 0 |
| 30 Nov 20 | 0 | -1 | 1 | 0 |
| 31 Aug 20 | 0 | -1 | 1 | 0 |
| 31 May 20 | 0 | -1 | 1 | 0 |
| 29 Feb 20 | 0 | -1 | 1 | 0 |
| 30 Nov 19 | 0 | -1 | 1 | 0 |
| 31 Aug 19 | 0 | -1 | 1 | 0 |
| 31 May 19 | 0 | -1 | 0 | 0 |
| 28 Feb 19 | 0 | -1 | 0 | 0 |
| 30 Nov 18 | 0 | -1 | 0 | 1 |
| 31 Aug 18 | 0 | -1 | 0 | 1 |
| 31 May 18 | 0 | -2 | 1 | 0 |
| 28 Feb 18 | 0 | -1 | 1 | 0 |
| 30 Nov 17 | 0 | -1 | 1 | 0 |
| 31 Aug 17 | 0 | -2 | 1 | 0 |
| 31 May 17 | 0 | -1 | 1 | 0 |
| 28 Feb 17 | 0 | -2 | 1 | 0 |
| 30 Nov 16 | 0 | -2 | 1 | 0 |
| 31 Aug 16 | 0 | -1 | 1 | 0 |
| 31 May 16 | 0 | -2 | 1 | 1 |
| 29 Feb 16 | 0 | -2 | 1 | 1 |
| 30 Nov 15 | 0 | -2 | 1 | 1 |
Quality Earnings: 9CX is currently unprofitable.
Growing Profit Margin: 9CX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9CX is unprofitable, but has reduced losses over the past 5 years at a rate of 11.3% per year.
Accelerating Growth: Unable to compare 9CX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 9CX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-37.2%).
Return on Equity
High ROE: 9CX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.